R. J. Meister

Randomized trial comparing the tolerability of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in cancer patients receiving myelosuppressive chemotherapy

Daniel I. Katcher, N. Robert, R. Beveridge, 1997, Supportive Care in Cancer.

Variant acute promyelocytic leukemia translocation (15;17) originating from two subsequent balanced translocations involving the same chromosomes 15 and 17 while preserving the PML/RARA fusion.

A. Meloni-Ehrig, C. Tirado, P. Mowrey, 2005, Cancer genetics and cytogenetics.

A comparison of efficacy of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in the therapeutic setting of chemotherapy-induced myelosuppression.

N. Robert, R. Beveridge, W. Taylor, 1998, Cancer investigation.